Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Brief Report July 22 2025
Three-year follow-up of low-dose, early-start gilteritinib maintenance in posttransplant patients with R/R FLT3mut AML
Brief Report July 16 2025
IgA or IgM MGUS less than 1.0 g/dL is at Low Risk of Progression to Neoplasm
Brief Report July 11 2025
Do all patients with chronic phase CML require a diagnostic bone marrow biopsy in the modern TKI era?
Brief Report July 11 2025
Deferring Treatment in Hairy Cell Leukemia: Is Active Surveillance Safe?
Brief Report July 11 2025
Elevated B12 serum levels are associated with the presence of Clonal Hematopoiesis
Research Article July 11 2025
Developmental Stage and Cellular Context Determine Oncogenic and Molecular Outcomes of Ezh2Y641F Mutation in Hematopoiesis
Research Article July 1 2025
Outcomes of Immune Checkpoint Inhibitor Rechallenge in Relapsed and/or Refractory Hodgkin Lymphoma
Brief Report June 30 2025
Posttranscriptional activity of eIF4E contributes to HoxA9-driven leukemogenesis
Research Article June 30 2025
Juvenile myelomonocytic leukemia stem cells are sensitive to NK cell-mediated lysis and express targetable antigens
Research Article June 30 2025
Intensive Chemotherapy vs. Venetoclax/Hypomethylating Agents for Patients Aged 60-75 with Favorable, NPM1-mutated AML
Review Article June 19 2025
Current Landscape of Frontline and Relapsed Follicular Lymphoma Trials
Research Article June 19 2025
GCK Inhibition Enhances Iberdomide Anti-Myeloma Effects by Promoting IKZF1 Degradation via a CRBN-Independent Mechanism
Brief Report June 14 2025
Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy
Research Article June 9 2025
Correlates of Organ Damage in Advanced Systemic Mastocytosis Patients Enrolled in Clinical Trials of Avapritinib
Research Article June 9 2025
Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: A Danish population-based study
Research Article June 9 2025
A Phase 1 Study of IO-202, an Anti-LILRB4 Antibody, in Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
Research Article June 3 2025
V-FAST: A phase 1b master trial to investigate CPX-351 combined with targeted agents in adults with newly diagnosed AML
Research Article June 3 2025
Targeting scavenger receptor class B type 1 with a bioinspired ligand induces apoptosis or ferroptosis in AML
Brief Report June 3 2025
Beat AML genetic risk stratification model in an older VEN/HMA-treated AML patient cohort
Research Article June 3 2025
Minimal residual disease measurement in blood by mass spectrometry identifies long-term responders in multiple myeloma.
Research Article May 19 2025
Replication of a GWAS signal near HLA-DQA2 with AML using a disease-only cohort and external population-based controls
Research Article May 19 2025
Outcomes and factors influencing survival in patients with diffuse large B cell lymphoma: a population-based analysis
Research Article May 19 2025
PPARγ-induced Upregulation of Fatty Acid Metabolism Confers Resistance to Venetoclax and Decitabine Therapy in AML.
Research Article May 19 2025
NAMPT haploinsufficiency is a collateral lethal therapeutic vulnerability in high-risk myeloid malignancies with TP53 inactivation
Research Article May 19 2025
An Antibody-Drug Conjugate Targeting VpreB1 for the Treatment of B-cell Acute Lymphoblastic Leukemia
Research Article May 12 2025
Real world performance of the CALGB 10403 regimen in young adults in the United States
Research Article May 11 2025
Prognostic impact of Extranodal Disease on PET/CT in Follicular Lymphoma: Results from a Validation Study with ECOG 2408
Research Article May 11 2025
Tagraxofusp, a CD123-Targeted Therapy, for Chronic Myelomonocytic Leukemia: Final Results of a Phase 1/2 Study
Research Article May 11 2025
Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia
Research Article May 11 2025
A Comparative Assessment of Molecular-Based Prognostic Models in CMML
Research Article May 11 2025
Gut Faecalibacterium abundance in patients with plasma cell disorders is associated with survival after autologous HSCT
Research Article April 25 2025
Targeting HASPIN kinase disrupts SR protein-mediated RNA splicing and synergizes with BCL-2 inhibitor venetoclax in AML
Research Article April 16 2025
Olfactory Receptors as Tumor Suppressors in Cutaneous T-Cell Lymphoma via p38γ Pathway Modulation

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals